Rang	Name	Position
1	Dr. Kaan Certel Ph.D.	President, CEO & Director
2	Dr. David A. Berry M.D., Ph.D.	Founder
3	Ms. Barbara Y. Chan CPA	Principal Financial Office, Principal Accounting Officer & Chief Accounting Officer
4	Dr. Jennifer Nelson Ph.D.	Chief Scientific Officer
5	Ms. Eva Stroynowski	Senior Vice President of Investor Relations & Corporate Affairs
6	Mr. Anthony Mullin	Chief People Officer
7	Mr. Charles O'Donnell Ph.D.	VP and Head of Computational Genomics & Data Sciences
8	Dr. Joe Newman Ph.D.	Senior Vice President of Early Discovery

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	UBS Group AG	0,30%	0,02 Mio. USD
2	Wells Fargo & Co	0,03%	0,00 Mio. USD
3	Barclays PLC	0,02%	0,00 Mio. USD
4	Steward Partners Investment Advisory, LLC	0,01%	0,00 Mio. USD
5	Principal Securities Inc	0,00%	0,00 Mio. USD
6	Royal Bank of Canada	0,00%	0,00 Mio. USD
7	683 Capital Management LLC	0,00%	0,00 Mio. USD
8	BlackRock Inc	0,00%	0,00 Mio. USD
9	Northern Trust Corp	0,00%	0,00 Mio. USD
10	Bridgeway Capital Management, LLC	0,00%	0,00 Mio. USD
11	Citadel Advisors Llc	0,00%	0,00 Mio. USD
12	Harbourvest Partners, LLC	0,00%	0,00 Mio. USD
13	Millennium Management LLC	0,00%	0,00 Mio. USD
14	BNP Paribas Arbitrage, SA	0,00%	0,00 Mio. USD
15	Morgan Stanley - Brokerage Accounts	0,00%	0,00 Mio. USD
16	Blue Owl Capital Holdings LP	0,00%	0,00 Mio. USD
17	Catalyst Funds Management Pty Ltd	0,00%	0,00 Mio. USD
18	Camden Capital Management, LLC	0,00%	0,00 Mio. USD
19	Long Corridor Asset Management Ltd	0,00%	0,00 Mio. USD
20	Advisor Group Holdings, Inc.	0,00%	0,00 Mio. USD